| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |